Improved gene transfer to neuroblastoma cells by a monoclonal antibody targeting RET, a receptor tyrosine kinase

Human Gene Therapy

Volumn 11, Issue 7, 2000, Pages 995-1004

  Yano, Lisa ^a   Shimura, Mari ^a   Taniguchi, Mika ^a   Hayashi, Yasuhide ^b   Suzuki, Toshimitsu ^c   Hatake, Kiyohiko ^d   Takaku, Fumimaro ^d   Ishizaka, Yukihito ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

ARTICLE; GENE LOCUS; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; NEUROBLASTOMA; PARKINSON DISEASE; TARGET CELL;

ANTIBODIES, MONOCLONAL; AVIDIN; BETA-GALACTOSIDASE; DNA; DROSOPHILA PROTEINS; EXTRACELLULAR MATRIX; GENE TRANSFER TECHNIQUES; GENES, REPORTER; HUMANS; NEUROBLASTOMA; NEURONS; PHEOCHROMOCYTOMA; POLYLYSINE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; RECOMBINANT PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034192389     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050015301     Document Type: Article

References (39)

1. Adam, S.A., Marr, R.S., and Gerace, L. (1990). Nuclear protein import in permeabilized mammalian cells requires soluble cytoplasmic factors. J. Cell Biol. 111, 807-816.
2. Chapel, A., Poncet, P., Neildez-Nguyen, T.M., Vetillard, J., Brouard, N., Goupy, C., Chavanel, G., Hirsch, F., and Thierry, D. (1999). Targeted transfection of the IL-3 gene into primary human hematopoietic progenitor cells through the c-kit receptor. Exp. Hematol. 27, 250-258.
3. Chen, C., and Okayama, H. (1987). High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell Biol. 7, 2745-2752.
4. Chen, J., Gamou, S., Takayanagi, A., and Shimizu, N. (1994). A novel gene delivery system using EGF receptor-mediated endocytosis. FEBS Lett. 338, 167-169.
5. Chen, J., Gamou, S., Takayanagi, A., Ohtake, Y., Ohtsubo, M., and Shimizu, N. (1998a). Targeted in vivo delivery of therapeutic gene into experimental squamous cell carcinomas using anti-epidermal growth factor receptor antibody: Immunogene approach. Hum. Gene Ther. 9, 2673-2681.
6. Chen, J., Gamou, S., Takayanagi, A., Ohtake, Y., Ohtsubo, M., and Shimizu, N. (1998b). Receptor-mediated gene delivery using the Fab fragments of anti-epidermal growth factor receptor antibodies: Improved immunogene approach. Cancer Gene Ther. 5, 357-364.
7. Cristiano, R.J., and Roth, J.A. (1996). Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor. Cancer Gene Ther. 3, 4-10.
8. Cristiano, R.J., Smith, L.C., and Woo, S.L.C. (1993). Hepatic gene therapy: Adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 90, 2122-2126.
9. Cüriel, D.T., Agarwal, S., Wagner, E., and Cotten, M. (1991). Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. Proc. Natl. Acad. Sci. U.S.A. 88, 8850-8854.
10. Durbec, P., Marcos-Gutierrez, C.V., Kilkenny, C., Grigoriou, M., Wartiowaara, K., Suvanto, P., Smith, D., Ponder, B., Costantini, F., Saarma, M., Sariola, H., and Pachnis, V. (1996). GDNF signalling through the Ret receptor tyrosine kinase. Nature (London) 381, 789-793.
11. During, M.J., Naegele, J.R., O'Malley, K.L., and Geller, A.I. (1994). Long-term behavioral recovery in Parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266, 1399-1403.
12. Erbacher, P., Bousser, M.-T., Raimond, J., Monsigny, M., Midoux, P., and Roche, A.C. (1996). Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages. Hum. Gene Ther. 7, 721-729.
13. Felgner, J.H., Kumar, R., Sridhar, C.N., Wheeler, C.J., Tsai, Y.J., Border, R., Ramsey, P., Martin, M., and Felgner, P.L. (1994). Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. 269, 2550-2561.
14. Forno, L.S., and Alvord, E.C. (1974). Depigmentation in the nerve cells of the substantia nigra and locus ceruleus in Parkinsonism. Adv. Neurol. 5, 195-202.
15. Foster, B.J., and Kern, J.A. (1997). HER2-targeted gene transfer. Hum. Gene Ther. 8, 719-727.
16. Gao, X., and Huang, L. (1996). Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry 35, 1027-1036.
17. Horellou, P., Sabaté, O., Buc-Caron, M.-H., and Mallet, J. (1997). Adenovirus-mediated gene transfer to the central nervous system for Parkinson's disease. Exp. Neurol. 144, 131-138.
18. Ikeda, I., Ishizaka, Y., Tahira, T., Suzuki, T., Onda, M., Sugimura, T., and Nagao, M. (1990). Specific expression of the ret proto-oncogene in human neuroblastoma cell lines. Oncogene 5, 1291-1296.
19. TPC oncogene product in cytoplasm. Oncogene 7, 1441-1444.
20. Itoh, F., Ishizaka, Y., Tahira, T., Yamamoto, M., Miya, A., Imai, K., Yachi, A., Tarai, S., Sugimura, T., and Nagao, M. (1992). Identification and analysis of the ret proto-oncogene promoter region in neuroblastom a cell lines and medullary thyroid carcinomas from MEN2A patients. Oncogene 7, 1201-1206.
21. Jing, S., Wen, D., Yu, Y., Holst, P.L., Luo, Y., Fang, M., Tamir, R., Antonio, L., Hu, Z., Cupples, R., Louis, J.-C., Hu, S., Altrock, B.W., and Fox, G.M. (1996). GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF. Cell 85, 1113-1124.
22. Morgenstern, J.P., and Land, H. (1990). Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587-3596.
23. Mulligan, L.M., Kwok, J.B.J., Healey, C.S., Elsdon, M.J., Eng, C., Gardner, E., Love, D.R., Mole, S.E., Moore, J.K., Papi, L., Ponder, M.A., Telenius, H., Tunnacliffe, A., and Ponder, B.A.J. (1993). Germ-line mutations of the RET protooncogene in multiple endocrine neoplasia type 2A. Nature (London) 363, 458-460.
24. Mulligan, L.M., Eng, C., Healey, C.S., Clayton, D., Kwok, J.B., Gargner, E., Ponder, M.A., Frilling, A., Jackson, C.E., Lehnert, H., Neumann, H.P.H., ThiBoseau, S.N., and Ponder, B.A.J. (1994). Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nature Genet. 6, 70-74.
25. Nagao, M., Ishizaka, Y., Nakagawara, A., Kohno, K., Kuwano, M., Tahira, T., Itoh, F., Ikeda, I., and Sugimura, T. (1990). Expression of ret proto-oncogene in human neuroblastomas. Jpn. J. Cancer Res. 81, 309-312.
26. Nakamura, T., Ishizaka, Y., Nagao, M., Hara, M., and Ishikawa, T. (1994). Expression of the ret proto-oncogene product in human normal and neoplastic tissues of neural crest origin. J. Pathol. 172, 255-260.
27. Plank, C., Oberhauser, B., Mechtler, K., Koch, C., and Wagner, E. (1994). The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J. Biol. Chem. 269, 12918-12924.
28. Schachtschabel, U., Pavlinkova, G., Lou, D., and Köhler, H. (1996). Antibody-mediated gene delivery for B-cell lymphoma in vitro. Cancer Gene Ther. 3, 365-372.
29. Schwarzenberger, P., Spence, S.E., Gooya, J.M., Michiel, D., Curiel, D.T., Ruscetti, F.W., and Keller, J.R. (1996). Targeted gene transfer to human hematopoietic progenitor cell lines through the c-kit receptor. Blood 87, 472-478.
30. Shimizu, N., Chen, J., Gamou, S., and Takayanagi, A. (1996). Immunogene approach toward cancer therapy using erythrocyte growth factor receptor-mediated gene delivery. Cancer Gene Ther. 3, 113-120.
31. Shimura, M., Zhou Y., Asada, Y., Yoshikawa, T., Hatake, K., Takau, F., and Ishizaka, Y. (1999). Inhibition of Vpr-induced cell cycle abnormality by quercetin: A novel strategy for screening compounds targeting Vpr. Biochem. Biophys. Res. Commun. 261, 308-316.
32. Shpetner, H., Joly, M., Hartley, D., and Corvera, S. (1996). Potential sites of PI-3 kinase function in the endocytic pathway revealed by the PI-3 kinase inhibitor, wortmannin. J. Cell Biol. 132, 595-605.
33. Tahira, T., Ishizaka, Y., Itoh, F., Sugimura, T., and Nagao, M. (1990). Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line. Oncogene 5, 97-102.
34. Takahashi, M., Buma, Y., and Taniguchi, M. (1991). Identification of the ret proto-oncogene products in neuroblastoma and leukemia cells. Oncogene 6, 297-301.
35. Takita, J., Hayashi, Y., Kohno, T., Yamaguchi, N., Hanada, R., Yamamoto, K., and Yokota, J. (1997). Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma. Cancer Res. 57, 907-912.
36. Treanor, J.J.S., Goodman, L., De Sauvage, F., Stone, D.M., Poulsen, K.T., Beck, C.D., Gray, C., Armanini, M.P., Pollock, R.A., Hefti, F., Phillips, H.S., Goddard, A., Moore, M.W., Buj-Bello, A., Davies, A.M., Asai, N., Takahashi, M., Vandlen, R., Henderson, C.E., and Rosenthal, A. (1996). Characterization of a multicomponent receptor for GDNF. Nature (London) 382, 80-83.
37. Trojan, J., Blossey, B.K., Johnson, T.R., Rudin, S.D., Tykocinski, M., Ilan, J., and Ilan, J. (1992). Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I. Proc. Natl. Acad. Sci. U.S.A. 89, 4874-4878.
38. Trupp, M., Arenas, E., Fainzilber, M., Nilsson, A.-S., Sieber, B.-A., Grigoriou, M., Kilkenny, C., Salazar-Grueso, E., Pachnis, V., Arumäe, U., Sariola, H., Saarma, M., and Ibáñez, C.F. (1996). Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature (London) 381, 785-789.
39. Wagner, E., Plank, C., Zatloukal, K., Cotten, M., and Birnstiel, M.L. (1992). Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: Toward a synthetic virus-like gene-transfer vehicle. Proc. Natl. Acad. Sci. U.S.A. 89, 7934-7938.